TISSUE REPAIR LTD — Director's Dealing 2025

Nov 25, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Tissue Repair Ltd (the “Company”) ABN 20 158 411 566

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alistair McKeough
Date of last notice	29 October 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [408 x 287] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct interest
Nature of indirect interest Nil
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 26 November 2025
No. of securities held prior to change Nil
Class 1) Unlisted Options
2) Ordinary Fully Paid Shares
Number acquired
1) 311,000 unlisted options exercisable at
$1.15 and expiring 26 November 2040
2) 30,000 Ordinary Fully Paid Shares
Number disposed Nil
Value/Consideration 1) Nil
Note: If consideration is non-cash, provide details and estimated 2) 0.2925 per share
valuation
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	1) 311,000 unlisted options exercisable at $1.15 and expiring 26 November 2040 2) 30,000 Ordinary Fully Paid Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	1) Issue of unlisted Options, as approved by Shareholders at the Company’s Annual General Meeting held on 24 November 2025. 2) On-market purchase.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [408 x 297] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A
----- End of picture text -----

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011